Living Cell Financials
| LVCLY Stock | USD 0.05 0 8.00% |
With this module, you can analyze Living financials for your investing period. You should be able to track the changes in Living Cell individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Living |
Understanding current and past Living Cell Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Living Cell's financial statements are interrelated, with each one affecting the others. For example, an increase in Living Cell's assets may result in an increase in income on the income statement.
The data published in Living Cell's official financial statements usually reflect Living Cell's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Living Cell Technologies. For example, before you start analyzing numbers published by Living accountants, it's critical to develop an understanding of what Living Cell's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Living Cell's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Living Cell's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Living Cell's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Living Cell Technologies. Please utilize our Beneish M Score to check the likelihood of Living Cell's management manipulating its earnings.
Living Cell Stock Summary
Living Cell competes with Covalon Technologies, and Ceapro. Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. The company was founded in 1987 and is based in Sydney, Australia. Living Cell operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US53838R1077 |
| Business Address | Tower 2, Sydney, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | www.lctglobal.com |
| Phone | 61 3 8689 9997 |
| Currency | USD - US Dollar |
You should never invest in Living Cell without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Living OTC Stock, because this is throwing your money away. Analyzing the key information contained in Living Cell's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Living Cell Key Financial Ratios
Generally speaking, Living Cell's financial ratios allow both analysts and investors to convert raw data from Living Cell's financial statements into concise, actionable information that can be used to evaluate the performance of Living Cell over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Living Cell Technologies reports annually and quarterly.Living Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Living Cell's current stock value. Our valuation model uses many indicators to compare Living Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Living Cell competition to find correlations between indicators driving Living Cell's intrinsic value. More Info.Living Cell Technologies is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Living Cell by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Living Cell's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Living Cell's earnings, one of the primary drivers of an investment's value.Living Cell Technologies Systematic Risk
Living Cell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Living Cell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Living Cell Technologies correlated with the market. If Beta is less than 0 Living Cell generally moves in the opposite direction as compared to the market. If Living Cell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Living Cell Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Living Cell is generally in the same direction as the market. If Beta > 1 Living Cell moves generally in the same direction as, but more than the movement of the benchmark.
About Living Cell Financials
What exactly are Living Cell Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Living Cell's income statement, its balance sheet, and the statement of cash flows. Potential Living Cell investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Living Cell investors may use each financial statement separately, they are all related. The changes in Living Cell's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Living Cell's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Living Cell Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Living Cell is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Living has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Living Cell's financials are consistent with your investment objective using the following steps:- Review Living Cell's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Living Cell's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Living Cell's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Living Cell's stock is overvalued or undervalued.
Living Cell April 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Living Cell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Living Cell Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Living Cell Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Living OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Living Cell's daily price indicators and compare them against related drivers.
| Downside Deviation | 28.98 | |||
| Information Ratio | 0.0503 | |||
| Maximum Drawdown | 86.67 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 25.0 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Living Cell Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Living OTC Stock analysis
When running Living Cell's price analysis, check to measure Living Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Living Cell is operating at the current time. Most of Living Cell's value examination focuses on studying past and present price action to predict the probability of Living Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Living Cell's price. Additionally, you may evaluate how the addition of Living Cell to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |